" class="no-js "lang="en-US"> Rob Wilson - Medtech Alert
Friday, January 17, 2025
Rob Wilson

Rob Wilson

About Rob Wilson

Rob Wilson leads the Performance Enzyme strategic business unit for Codexis and has been with the company since 2006. He has held a variety of business-operational roles at Codexis, across Biotherapeutics and Performance Enzymes, in postings in Europe, Asia and the USA. Prior to joining Codexis, Rob worked for 7 years in various business-technical roles for Avecia – a major UK-based custom manufacturer of intermediates and APIs for the Pharma industry. Today, Rob is P&L responsible for Performance Enzymes and leads a broad-based team at Codexis, responsible for building business and executing projects in existing and emerging markets for the industrial application of improved proteins. He earned a BSc in chemistry and a Ph.D. in organic chemistry from the University of Leeds in the UK.

Related Story

Codexis and seqWell Announce Strategic Investment and Partnership Initiation

April 25 2022

Codexis, Inc. (Nasdaq: CDXS) and seqWell, Inc. today announced the initiation of a strategic partnership […]